The effects of quinidine, ajmaline, papaverine and adrenergic beta-receptor inhibitors in experimental BaCl2-arrhythmia developed for the quantitative assay of antiarrhythmic drugs.
D000470:Alkaloids; D000818:Animals; D001145:Arrhythmias, Cardiac; D001464:Barium / Q000008:administration & dosage*; D002712:Chlorides / Q000008:administration & dosage; D004562:Electrocardiography; D004983:Ethanolamines / Q000008:administration & dosage; D005260:Female; D007275:Injections, Intravenous; D007545:Isoproterenol / Q000008:administration & dosage; D008297:Male; D010208:Papaverine; D011433:Propranolol / Q000008:administration & dosage; D011802:Quinidine; D011807:Quinolizines; D011817:Rabbits; D013565:Sympatholytics / Q000008:administration & dosage*
D000470:Alkaloids; D002712:Chlorides; D004983:Ethanolamines; D011807:Quinolizines; D013565:Sympatholytics; D001464:Barium; D011433:Propranolol; D010208:Papaverine; D011802:Quinidine; D007545:Isoproterenol